PLX - Protalix BioTherapeutics, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts2022
Avg. Estimate-0.030-0.230.01
Low Estimate-0.060-0.31-0.19
High Estimate0.010-0.150.21
Year Ago EPS-0.06-0.06-0.61-0.23
Revenue EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts2122
Avg. Estimate10.95M16.5M22.79M50.85M
Low Estimate9M16.5M16.3M24.2M
High Estimate12.9M16.5M29.29M77.5M
Year Ago Sales2.47M4.55M19.24M22.79M
Sales Growth (year/est)343.50%262.40%18.40%123.10%
Earnings History12/30/20173/30/20186/29/20189/29/2018
EPS Est.-0.06-0.09-0.06-0.04
EPS Actual-0.06-0.06-0.08-0.1
Difference00.03-0.02-0.06
Surprise %0.00%33.30%-33.30%-150.00%
EPS TrendCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Current Estimate-0.030-0.230.01
7 Days Ago-0.030.04-0.230.01
30 Days Ago-0.030.04-0.220.02
60 Days Ago-0.030.04-0.220.02
90 Days Ago-0.020.04-0.190.02
EPS RevisionsCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1N/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesPLXIndustrySectorS&P 500
Current Qtr.50.00%N/AN/A0.48
Next Qtr.N/AN/AN/A0.40
Current Year62.30%N/AN/A0.21
Next Year104.30%N/AN/A0.10
Next 5 Years (per annum)25.00%N/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A